Updated On: 15 December, 2025 09:48 AM IST | New Delhi | IANS
In the first prospective multicentre thrombectomy (procedure to physically remove a blood clot from a blocked artery) trial, the Supernova stent retriever achieved high successful restoration of blood flow with brain bleed, mortality and functional independence at 90 days

Image for representational purpose only. Photo Courtesy: File pic
The Supernova Stent -- a new and advanced brain treatment device -- has been demonstrated to be safe and effective for stroke patients, said experts at AIIMS Delhi on Saturday, who led the first clinical trial.
AIIMS Delhi was the national coordinating centre and the lead enrolling site of the GRASSROOT trial for the Supernova Stent.